Can we use HbA1c as a biomarker for predicting the short-term outcome after acute myocardial infarction?
4 May 2019 (08:30 - 16:30)
Organised by:
About the speaker
Zagazig University Hospitals, Zagazig (Egypt)
6 More presentations in this session
Access the full session
The Event
EuroHeartCare 2019
4 May 2019
08:30 CET
